Abstract: Abstract: Abstract: Abstract: Abstract: Pattern recognition receptors (PRRs) constitute a pivotal arm of innate immunity. Their distribution is widespread and not limited to cells of the immune system. Following our previous findings concerning the expression of Toll-like receptors (TLRs) 2, 3 and 4 in chronic viral hepatitis C of children, we wished to search for other PRRs, including other TLRs, NOD-like receptors (NLRs) and RIG-1-like helicase receptors (RLR) in infected hepatocytes. Liver biopsy fragments from ten children with chronic hepatitis B and C were used and two others in which hepatotropic virus infection was excluded. Frozen sections of liver samples were subjected to ABC immunohistochemistry (IHC) following incubation with a set of antibodies. Results of IHC findings were screened for correlation with clinical/laboratory data of patients. It was found that several PRRs could be shown in affected hepatocytes, but the incidence was higher in hepatitis C than in B. In hepatitis C, TLR1, 2, 4, NALP and RIG-1 helicase showed the most marked expression. In hepatitis B, TLR1, 3, 9, NOD1 and NALP expression were the most conspicuous. Expression PRRs in liver from hepatitis of unknown origin was much lower. It was also the case in cytospins from human hepatoma cell line. Several correlations between PRRs expression and clinical findings in patients could be shown by statistical exploration. In conclusion, this data suggests some role for PRRs in the pathogenesis of chronic viral hepatitis.
Expression of pattern recognition receptors Expression of pattern recognition receptors Expression of pattern recognition receptors Expression of pattern recognition receptors
Expression of pattern recognition receptors in liver biopsy specimens of children in liver biopsy specimens of children in liver biopsy specimens of children in liver biopsy specimens of children in liver biopsy specimens of children chronically infected with HB chronically infected with HB chronically infected with HB chronically infected with HB chronically infected with HBV and HCV V and HCV V and HCV V and HCV V and HCV Hepatotropic viruses, both hepatitis B virus (HBV) and hepatitis C virus (HCV), remain important pathogenic agents of man, including children. Both viruses rarely induce acute hepatitis in young patients. Symptomless periods of infection quite often lead, however, to the chronic stage of the disease with several consequences such as liver cirrhosis and hepatocellular carcinoma [1] . The pathogenesis of chronic viral hepatitis is relatively well known. Viruses induce an adaptive immune response in the infected host, which however is usually unable to eradicate them from the body. [4] [5] [6] . Pattern recognition receptors (PRRs) are considered now to play a pivotal role in innate immunity. They are expressed predominantly on cells of the immune system, but have been also shown on various epithelia, including hepatocytes [7, 8] . PRRs are expressed on immune cells, especially on antigen-presenting ones (APC), and participate in the induction of adaptive immunity. Ligands recognized by PRRs are the molecules present on or in pathogens such as viruses, bacteria, fungi and protozoa, being essential for their growth and survival. They include various complex lipids, sugars, nucleic acids, collectively termed pathogen-associated molecular patterns (PAMPs). PRRs comprise several families including Toll-like receptors (TLRs), NOD -nucleotide binding oligomerization domain like receptors (NLRs) and Rig-like helicase receptors (RLR). The best known are TLRs, subdivided now into 11 subgroups in man, according to the specificity of recognized PAMPs. NLRs are relatively newly described intracellular PRRs, consisting of at least 22 members, activated mainly by various bacterial peptidoglycans. RLRs are also intracellular and participate in antiviral defense by promoting type I interferon (IFN) synthesis [9] [10] [11] .
We have shown three TLRs, namely TLR2, 3 and 4 in liver biopsy tissue sections of children chronically infected with HCV [8] . In the current study, we wanted to learn whether other TLRs, some NLRs and RLRs are also expressed in infected hepatocytes of children suffering from both chronic HBV and HCV hepatitis. Furthermore, we wished to seek a possible relationship between PRRs expression and clinical data of infected children. It will be shown, albeit on a small group of patients, that some links between PRR expression and clinical status of patients really do exist.
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atients. atients. They were five children, all boys, chronically infected with HBV, aged from six to 14 years, (median age 9.6 years.). Their diagnosis was confirmed both by serological and molecular criteria. Another five children had chronic hepatitis C, including four boys and one girl, aged from eight to 17 years (median age 14.4 years). HCV infection was based on the criteria as above. All ten patients were subjected to percutaneous liver biopsy in order to establish advancement of disease. Informed consent for this procedure was obtained either from parents or the children themselves. Clinical and laboratory data of the patients is shown in Table 1 .
Apart from the infected patients, two other boys of comparable age were tested along with those shown above, in which HBV and HCV infection was excluded, but liver biopsy was performed for diagnostic purposes. In the first boy, chronic hepatitis of unknown origin was diagnosed. In the second, a diagnosis of autoimmune hepatitis was finally established. In addition, cell sediments from human hepatoma cell line were tested in parallel. These three specimens were later called 'others'. ABC immunohistochemistry. ABC immunohistochemistry. ABC immunohistochemistry. ABC immunohistochemistry. ABC immunohistochemistry. In brief, fragments of liver tissue obtained during biopsy were snap-frozen in dry iceacetone slurry and stored at -70°C until used. Cryostat 4 μm sections from liver blocks were then cut (n = 4-5), positioned on each microscopic slide, air-dried, fixed for 5 min in the cold acetone. Endogenous peroxidase was abolished by the treatment of sections with methanol with 0.6% hydrogen peroxide for 20 minutes. To avoid non-specific staining, sections were incubated with 1.5% normal goat serum for one hour.
Primary goat anti-particular PRR antibody was then applied and sections were incubated overnight in a humid chamber in the cold. Primary goat anti-PRRs antibodies used were all from Santa Cruz Biotechnology, CA, USA, and were the same as used previously [12] . The next day, sections were washed thrice with cold PBS and thereafter subjected to biotinylated donkey anti-goat IgG for 30 min. After washing, the next incubation was with avidin solution, followed by biotinylated horseradish peroxidase (HRP). After subsequent washing steps, substrate solution containing hydrogen peroxide and diaminobenzidine (DAB) was applied. After washing, sections were counterstained with Meyer hematoxylin and embedded in glycerogel. For the whole ABC procedure, a commercial kit (Santa Cruz) was used. Negative control reactions included: -omitting primary antibody and using normal goat serum instead; -performing the reaction on sections of normal human liver (from surgery). Both control reactions came out completely negative. As a positive control reaction, frozen sections of human tonsil were run in parallel. This was of limited value, because several PRRs could not be demonstrated in lymphoid cells.
Additionally, cell cytospins of human hepatoma (Hep-62) cell line were subjected to the same immunohistochemical procedure as above. Primary antibodies applied were the same as those used for tissue sections. , manifested viremia in the blood. Values of hepatic enzymes (ALT and AST) were raised in almost all patients, but the rise was higher in the HBV + group. Histology of biopsy specimens showed weakly expressed changes in the majority of patients classified as G1S1. All children, with the exception of one (K.P.), were before antiviral therapy. Clinical and laboratory data of all patients tested is set out in Table 1 .
When frozen sections of biopsy liver tissue fragments were subjected to PRR antibodies and ABC immunohistochemistry (IHC), the results varied from patient to patient and from one PRR to another (Table 2 ). In general, the number of PRR positive liver samples and number of scores in individual cases were higher in hepatitis C than in hepatitis B biopsies. Within the TLRs family, approximately the same receptors were most frequently expressed in both diseases tested. They included TLR1, 2, 3, 4, 9 and 10. In the NLR group, all receptors tested, namely NOD1, NOD2, NALP1, Cryopiryn (NALP3) and CARD12, were more strongly expressed in hepatitis C compared to hepatitis B liver sections. In the RNL group represented by two receptors, RIG-1 and MDA-5, the former predominated, mainly in hepatitis C samples. Examples of IHC staining are shown in composite Figure 1 (A-H) . As can be seen in Table 2 , mean values of numerical scores were higher in hepatitis C than in hepatitis B for almost all PRRs tested. The mean of the so called 'control group' was lower than those of both examined groups. The only exception was the mean of cryopiryn (NALP3) in which the mean in hepatitis B was lower than in the 'control' group. TLR  TLR TLR  TLR  TLR1  1 1  1  1   TLR2  TLR2 TLR2  TLR2  TLR2   TLR3  TLR3 TLR3  TLR3  TLR3   TLR4  TLR4 TLR4  TLR4  TLR4   TLR5  TLR5 TLR5  TLR5  TLR5   TLR6  TLR6 TLR6  TLR6  TLR6   TLR7  TLR7 TLR7  TLR7  TLR7   TLR8  TLR8 TLR8  TLR8  TLR8   TLR9  TLR9 TLR9  TLR9  TLR9   TLR  TLR TLR  TLR  TLR10  10 The numerical scores of all PRRs for individual patients were also added and divided by the number of PRRs tested. The sum of these values in hepatitis B (n = 5) was compared to that in hepatitis C. It turned out that the sum of hepatitis B was lower than that of hepatitis C (6.2 vs. 8.0). When these values were subjected to ANOVA and post-hoc statistics, the difference between HBV and HCV sums was not significant, but between HCV and the 'others' it was (p = 0.020). There was no visible correlation between total PRR counts and clinical/laboratory data in HBV + patients. In the HCV + group, however, the highest combined PRR value was noticed in the patient (BA) with the highest viremia.
The so-called 'others' group included one hepatitis of unknown origin, HBV and HCV negative. The results presented here show that human hepatocytes infected either with HBV or HCV express several PRRs. In hepatitis B, the most frequent incidence of TLRs included TLR1, 2, 3, 4, 9 and 10, but also NOD1 and NALP1. In hepatitis C, the same PRRs appeared the most frequently, but also NOD2, Cryopiryn (NALP3) and RIG1-like helicase could be demonstrated. It is of interest that hepatocytes from an autoimmune hepatitis case have shown a similar pattern of PRR expression to those of a chronic viral one. This suggests that PRRs ligands may be analogous in both pathological conditions. The reason for such vast PRR expression in these diseases is unknown and any attempts of explanation can only be speculative. Wei et al. [7] have found however, that TLR4 expression in hepatocytes positively correlated with grading scores. In the current study, it was not possible to pinpoint any rules governing PRR expression in individual liver specimens. PRRs do not recognize only PAMPs i.e. molecular patterns of various pathogens. Some of them recognize however products of metabolism or degradation of the body such as uric acid, apoptotic bodies, heat shock proteins and others, collectively termed 'Danger Associated Molecular Patterns' (DAMPs). It is likely that several metabolic end-products formed intracellularly in infected hepatocytes may be recognized by intracellular PRRs such as NLRs. It is known that some NLRs such as NALP3 form intracellular multimolecular complex with caspase-1 termed inflammasome involved in the regulation of secretion of proinflammatory cytokines such as IL-1 [10] . It certainly might trigger an inflammatory reaction against DAMPs. The latter are apparently abundant in liver cells due to the high metabolic turnover in this organ. Activators of NLRs are poorly understood. It is known, for example, that NALPs, members of the NLR family, may be triggered by hypotonic stress, possibly due to the release or activation of some 'danger signal' [13] [14] [15] [16] . Such danger signals may originate from cell degradation product following viral infection. NLRs were so far known to be triggered by bacterial peptidoglycans, components of bacterial cell wall. The data from the current study indicates that they can be also triggered by other molecules, not necessarily of bacterial origin. Higher expression of PRRs in hepatitis C samples compared to HBV ones, although not significant, suggests some hints for this conundrum. As shown in Table 2 , means of almost all PRRs were higher in the former group. The sums of numerical values of individual patients divided by the number of PRRs tested were also higher in the HCV group. One possible explanation of the difference in the PRR expression in infected hepatocytes by HCV as compared to HBV ones may be the median age of affected children. The HBV group was younger than the HCV one. This may www.fhc.viamedica.pl imply some immaturity of the immune system and some metabolic processes within cells governing PRRs responses both to viral and own wasted products corresponding to PAMPs and DAMPs. Recently new roles for PRR NLRs in the liver have been proposed. It has been shown that hepatocytes express functional NOD1 and NOD2. Stimulation of NOD1 with its ligand (C12-iEDAP) resulted in NF-kappa B activation, CCL5 (RANTES) and CXCL1 chemokine production [17] . In hepatitis C, it was postulated that HCV can subvert PRRs mediated control of adaptive immunity dependent on dendritic cells [18] . Components of RLR family were less frequently demonstrated in examined biopsies. Nevertheless, RIG-1 like helicase was seen in two cases of hepatitis B and in three ones of hepatitis C, while MDA-5 was evident in only one hepatitis B specimen. This may correspond to the relatively low inflammatory intensity in most examined liver tissues as depicted by grading and staging (G1S1) scores. On the other hand, it is known that RLRs and in particular RIG-1 helicase participate in triggering type I interferon secretion following viral infection [19] . It has been shown recently by Hoffman et al. that RIG-1 polymorphism has an influence on its activity during HCV infection [20] .
In spite of the small number of patients, we decided to search for possible correlations between PRR expression and some clinical/laboratory data, being aware of its constraints. Unexpectedly, some correlations could be noticed, either significant or borderline. The former included higher expression of NOD2 in hepatitis C compared to B and relatively frequent incidence of TLR3 in both hepatidines. The latter finding may be the reflection of viral etiology of both diseases and TLR3 propensity for nucleic acids. It was further supported by the presence of significant correlation between TLR3 and viremia. TLR3 has also shown borderline correlation with two NLR members, namely CARD12 (caspase recruitment domain) and cryopiryn (NALP3). The reasons for this are obscure, but it is well known that caspase activation is associated with apoptosis (hepatocytes?).
In conclusion, it appears tempting to postulate that PRRs play some role in the pathogenesis of viral hepatitis B and C. This is supported even by their vast expression in the hepatocytes of an affected liver, and virtually total absence, at least by IHC screening, from normal ones. 
